Vascular Solutions (VASC) Stock Price, News & Analysis

Company Overview

Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company's product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company's product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.

Key Stats

• Today's Range: $56.00 to $56.00
• 50-Day Range: N/A
• 52-Week Range: $25.06 to $57.15
• Volume: N/A
• Average Volume: 248,891 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VASC Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Vascular Solutions own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vascular Solutions investors own include Teleflex (TFX), ReShape Lifesciences (RSLS), Tourmaline Oil (TOU), TransEnterix (TRXDW), Arrowhead Pharmaceuticals (ARWR), Bausch Health Companies (BHC) and Hologic (HOLX).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Health Care Supplies
• Current Symbol: NASDAQ:VASC
• CUSIP: 92231M10
• CIK: 1030206
• Web: vasc.com
• Phone: +1-763-6564300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A